375 related articles for article (PubMed ID: 15975024)
1. Non-human primate models for AIDS vaccine research.
Hu SL
Curr Drug Targets Infect Disord; 2005 Jun; 5(2):193-201. PubMed ID: 15975024
[TBL] [Abstract][Full Text] [Related]
2. The roles of nonhuman primates in the preclinical evaluation of candidate AIDS vaccines.
Staprans SI; Feinberg MB
Expert Rev Vaccines; 2004 Aug; 3(4 Suppl):S5-32. PubMed ID: 15285703
[TBL] [Abstract][Full Text] [Related]
3. Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates.
Le Grand R; Dereuddre-Bosquet N; Dispinseri S; Gosse L; Desjardins D; Shen X; Tolazzi M; Ochsenbauer C; Saidi H; Tomaras G; Prague M; Barnett SW; Thiebaut R; Cope A; Scarlatti G; Shattock RJ
J Virol; 2016 Jun; 90(11):5315-5328. PubMed ID: 27009957
[TBL] [Abstract][Full Text] [Related]
4. The use of nonhuman primate models of HIV infection for the evaluation of antiviral strategies.
Van Rompay KK
AIDS Res Hum Retroviruses; 2012 Jan; 28(1):16-35. PubMed ID: 21902451
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of AIDS vaccine strategies in nonhuman primates.
Uberla K
Med Microbiol Immunol; 2005 Aug; 194(4):201-6. PubMed ID: 15843997
[TBL] [Abstract][Full Text] [Related]
6. A combination DNA and attenuated simian immunodeficiency virus vaccine strategy provides enhanced protection from simian/human immunodeficiency virus-induced disease.
Amara RR; Patel K; Niedziela G; Nigam P; Sharma S; Staprans SI; Montefiori DC; Chenareddi L; Herndon JG; Robinson HL; McClure HM; Novembre FJ
J Virol; 2005 Dec; 79(24):15356-67. PubMed ID: 16306607
[TBL] [Abstract][Full Text] [Related]
7. Long-term protection against SIV-induced disease in macaques vaccinated with a live attenuated HIV-2 vaccine.
Putkonen P; Walther L; Zhang YJ; Li SL; Nilsson C; Albert J; Biberfeld P; Thorstensson R; Biberfeld G
Nat Med; 1995 Sep; 1(9):914-8. PubMed ID: 7585217
[TBL] [Abstract][Full Text] [Related]
8. Monkey Models and HIV Vaccine Research.
Chen Z
Adv Exp Med Biol; 2018; 1075():97-124. PubMed ID: 30030791
[TBL] [Abstract][Full Text] [Related]
9. Tackling HIV and AIDS: contributions by non-human primate models.
Van Rompay KKA
Lab Anim (NY); 2017 May; 46(6):259-270. PubMed ID: 28530684
[TBL] [Abstract][Full Text] [Related]
10. Is an HIV vaccine possible?
Wilson NA; Watkins DI
Braz J Infect Dis; 2009 Aug; 13(4):304-10. PubMed ID: 20231996
[TBL] [Abstract][Full Text] [Related]
11. A clinically relevant HIV-1 subunit vaccine protects rhesus macaques from in vivo passaged simian-human immunodeficiency virus infection.
Mooij P; van der Kolk M; Bogers WM; ten Haaft PJ; Van Der Meide P; Almond N; Stott J; Deschamps M; Labbe D; Momin P; Voss G; Von Hoegen P; Bruck C; Heeney JL
AIDS; 1998 Mar; 12(5):F15-22. PubMed ID: 9543435
[TBL] [Abstract][Full Text] [Related]
12. Reduced Cell-Associated DNA and Improved Viral Control in Macaques following Passive Transfer of a Single Anti-V2 Monoclonal Antibody and Repeated Simian/Human Immunodeficiency Virus Challenges.
Hessell AJ; Shapiro MB; Powell R; Malherbe DC; McBurney SP; Pandey S; Cheever T; Sutton WF; Kahl C; Park B; Zolla-Pazner S; Haigwood NL
J Virol; 2018 Jun; 92(11):. PubMed ID: 29514914
[TBL] [Abstract][Full Text] [Related]
13. Using SHIVs to develop an anti-HIV-1 live-attenuated vaccine.
Kuwata T; Miura T; Hayami M
Trends Microbiol; 2001 Oct; 9(10):475-80. PubMed ID: 11597447
[TBL] [Abstract][Full Text] [Related]
14. Simian and feline immunodeficiency viruses: animal lentivirus models for evaluation of AIDS vaccines and antiviral agents.
Gardner MB
Antiviral Res; 1991 May; 15(4):267-86. PubMed ID: 1659310
[TBL] [Abstract][Full Text] [Related]
15. Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239.
Abel K; Rourke T; Lu D; Bost K; McChesney MB; Miller CJ
J Infect Dis; 2004 Nov; 190(9):1697-705. PubMed ID: 15478078
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and efficacy of DNA/MVA HIV vaccines in rhesus macaque models.
Chea LS; Amara RR
Expert Rev Vaccines; 2017 Oct; 16(10):973-985. PubMed ID: 28838267
[TBL] [Abstract][Full Text] [Related]
17. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.
Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection.
Liu Q; Li Y; Luo Z; Yang G; Liu Y; Liu Y; Sun M; Dai J; Li Q; Qin C; Shao Y
AIDS; 2015 Mar; 29(6):649-58. PubMed ID: 25849828
[TBL] [Abstract][Full Text] [Related]
20. Poxvirus-based vaccine candidates for HIV: two decades of experience with special emphasis on canarypox vectors.
Franchini G; Gurunathan S; Baglyos L; Plotkin S; Tartaglia J
Expert Rev Vaccines; 2004 Aug; 3(4 Suppl):S75-88. PubMed ID: 15285707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]